Scientific Sessions 2025  /  New Insights and Treatment Options in Diabetes Associated Cardiometabolic Disease  /  Development of mimetic peptides that slow progression and promote regression of type 1 diabetes mellitus
Logo

American Heart Association

  86
  0

Final ID:

Development of mimetic peptides that slow progression and promote regression of type 1 diabetes mellitus

  • Rye, Kerry-anne  ( UNIV NEW SOUTH WALES , Sydney , New South Wales , Australia )
  • Cochran, Blake  ( UNSW Sydney , Unsw Sydney , New South Wales , Australia )
    • Author Disclosures:
    Kerry-Anne Rye: DO NOT have relevant financial relationships | Blake Cochran: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

New Insights and Treatment Options in Diabetes Associated Cardiometabolic Disease

Friday, 11/07/2025 , 02:15PM - 03:30PM

Cardiovascular Seminar

More abstracts on this topic:
RAGE/DIAPH1 and New Therapeutic Approaches in Cardiometabolic Disease

Schmidt Ann Marie, Davidson W, Von Eckardstein Arnold

Targeting Endothelial IGF2 Ameliorates Wound Healing in Diabetes

Chen Hong, Shi Jinjun

More abstracts from these authors:
The JLR

Rye Kerry-anne

Partial loss of macrophage Ripk1 drives atheroprotection in Ldlr-/- Mice and is controlled by ApoAI–IL-10-STAT3 anti-inflammatory signaling.

Xu Han, Nicholls Stephen, Murphy James, Bursill Christina, Rye Kerry-anne, Karunakaran Denuja, Sato Masaaki, Fernando Shevin, Cochran Blake, Nankivell Victoria, Tapia Caceres Felipe, Wang Yizhuo, Bisht Kavita, Denton Kate

You have to be authorized to contact abstract author. Please, Login
Not Available